Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 10, 2001

View Archived Issues

Affibody Raises US$28M For Programs In Antibody Mimics

EU Court Backs Biotechnology Patents, Dismisses Challenge

Biotechnica Trade Fair Draws Record Number Of Exhibitors

Gene Sequence Of Plague Agent Could Lead To New Therapies

Scottish Officials Devise Plan To Support Local Development

Other News To Note

Australian Company ACT Starts Vaccine Studies Against P53

Endocube Sets Out To Discover New Anti-Inflammatory Therapies

Biobank Aims To Help Biotech Start-Ups Take Root and Develop

Euro Commission Report Says GM Plants Show No New Risks

Germany Supports Another 7 Nanobiotechnology Projects

Microscience, Anadis Enter Deal Around STM Technology

SR Pharma Says Data Support Continued SRL172 Development

Synt:em, BLSI Collaborate To Optimize CNS Diagnostic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...